TNFRSF10B and lung carcinoma: Similar results were also obtained in H460 and primary human lung cancer cells (“Pat-2”), where TRAIL plus DR5 siRNA knockdown or caspase-8 inhibition (z-IETD-fmk) significantly alleviated ONC201’s cytotoxicity.